Literature DB >> 30047822

Sero-epidemiological evaluation of rubella immunity among pre-marriage women in Iran.

Seyed Mohsen Zahraei1, Talat Mokhtari-Azad2, Azam Sabouri1, Salman Khazaei3, Manoochehr Karami4,5.   

Abstract

Few studies have addressed the seroepidemiological profile of rubella among a representative population of young adult women. This study aims to determine the immunity and susceptibility rate against rubella in a representative population of women in reproductive age in Iran through serological evaluation. This cross-sectional study was conducted in 2012 on 804 pre-marriage women in Iran. Multi-stage random sampling was used for choosing study sample. Serologic test were used to assess subjects' immunity to rubella and their titers of IgG antibody against rubella with ELISA method was measured. In total, 98.4% (95% CI: 97.5% -99.2%) of study participants were immune against rubella. Five women (0.6%) were in borderline category and 1% (8 women) was susceptible to rubella. The proportion of immune people in low and high incidence regions was 99.3% (95% CI: 97.8-99.9%), and 97.5% (95% CI: 96.4-98.5%), respectively (P = 0.05). Our data indicated that level of immunity to rubella in women of reproductive age in Iran is satisfactory. This finding indicates the achievement of Iran to the goal of high level of serum immunity against rubella among young women.

Entities:  

Keywords:  immunity; rubella; seroepidemiology; vaccination; women

Mesh:

Substances:

Year:  2019        PMID: 30047822      PMCID: PMC6773378          DOI: 10.1080/21645515.2018.1504527

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  15 in total

1.  Seroprevalence of rubella antibodies among antenatal patients in the Western Cape.

Authors:  Craig Corcoran; Diana R Hardie
Journal:  S Afr Med J       Date:  2005-09

2.  Reducing the global burden of congenital rubella syndrome.

Authors:  Susan E Reef; Susan Y Chu; Stephen L Cochi; Robert Kezaala; Maya van den Ent; Andrea Gay; Ciro de Quadros; Peter M Strebel
Journal:  Lancet       Date:  2012-09-29       Impact factor: 79.321

3.  Framework for verifying elimination of measles and rubella.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-03-01

4.  Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.

Authors:  Ning Song; Zhanhai Gao; James G Wood; Linda Hueston; Gwendolyn L Gilbert; C Raina MacIntyre; Helen E Quinn; Robert Menzies; Peter McIntyre
Journal:  Vaccine       Date:  2012-05-01       Impact factor: 3.641

5.  Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy.

Authors:  Sebastiano Calimeri; Adele Capua; Vincenza La Fauci; Raffaele Squeri; Orazio C Grillo; Daniela Lo Giudice
Journal:  Int J Gynaecol Obstet       Date:  2012-01-09       Impact factor: 3.561

6.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

7.  Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes.

Authors:  Maria Kakoulidou; Marianne Forsgren; Ilona Lewensohn-Fuchs; Kari Johansen
Journal:  Vaccine       Date:  2009-11-29       Impact factor: 3.641

8.  Progress in measles and rubella elimination in Iran.

Authors:  Abdoulreza Esteghamati; Mohammad Mehdi Gouya; Seyed Mohsen Zahraei; Mohammad Nasr Dadras; Armin Rashidi; Frank Mahoney
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129

9.  Seroprevalence of rubella in northeastern Turkey.

Authors:  Yasemin Akkoyunlu; Gulhan Arvas; Tamer Ozsarı; Ismail Necati Hakyemez; Bulent Kaya; Turan Aslan
Journal:  Wien Klin Wochenschr       Date:  2013-06-21       Impact factor: 2.275

10.  Evaluation of rubella IgG antibodies among women at marriage in kermanshah city, before and after mass vaccination.

Authors:  Hossein Hatami; Feizollah Mansouri; Yadollah Mehrabi; Hengameh Namdari; Maryam Hatami
Journal:  Int J Prev Med       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.